Melbourne Renal Research Group

Melbourne VIC 3073

0 studies enrolling now · 2 studies all time

What they study most

Alport Syndrome, Polycystic Kidney Disease, Autosomal Dominant

Studies at this site

• A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL — Completed
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Completed